ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
London-based AI drug discovery startup Boltz raised $110m in Series A funding led by Bessemer Venture Partners. The round brings total capital to $138M, with participation from Andreessen Horowitz and others. CEO Gabriele Corso plans to invest in compute and expand the team.
Tap to vote and see what everyone thinks.
Summary by ByteBrief